Question to the Department of Health and Social Care:

To ask Her Majesty's Government, following the report in the Sunday Times on 14 January that the Ministry of Defence had stated that respected health bodies continued to recommend Lariam "as a safe and effective form of malaria prevention", which bodies provide such a recommendation.

Mefloquine is effective in the prevention and treatment of malaria and is licensed for use by the Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medication in the United Kingdom. As with all medicines, the MHRA keeps the safety of mefloquine under continual review.

Bodies such as the Advisory Committee on Malaria Prevention, the World Health Organization and the United States Centers for Disease Control and Prevention continue to include mefloquine as an option for malaria chemoprophylaxis.